Molecular profiling of advanced breast cancer tumors is beneficial in assisting clinical treatment plans.
Carter P, Alifrangis C, Cereser B, Chandrasinghe P, Del Bel Belluz L, Moderau N, Poyia F, Schwartzberg LS, Tabassum N, Wen J, Krell J, Stebbing J.
Carter P, et al. Among authors: cereser b.
Oncotarget. 2018 Feb 24;9(25):17589-17596. doi: 10.18632/oncotarget.24564. eCollection 2018 Apr 3.
Oncotarget. 2018.
PMID: 29707132
Free PMC article.